Trials / Unknown
UnknownNCT02558517
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment (Prednisone 5 Milligram Per Day) in Quiescent Systemic Lupus
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 136 (estimated)
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Systemic Lupus (SLE) is a chronic disease for which long term treatments are warranted. The aim of this study was to study the possibility of corticosteroids interruption in patients with quiescent SLE treated since at least one year with 5 milligrams of predonisone per day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisone discontinuation | randomization |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2017-01-01
- Completion
- 2018-01-01
- First posted
- 2015-09-24
- Last updated
- 2016-08-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02558517. Inclusion in this directory is not an endorsement.